AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 86 filers reported holding AVADEL PHARMACEUTICALS PLC in Q4 2021. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $469,536 | -37.5% | 45,586 | 0.0% | 0.10% | +35.7% |
Q2 2023 | $751,257 | +929.1% | 45,586 | +52.0% | 0.07% | +1066.7% |
Q2 2022 | $73,000 | -91.6% | 30,000 | -72.2% | 0.01% | -88.7% |
Q4 2021 | $873,000 | +52.4% | 108,079 | +84.7% | 0.05% | +211.8% |
Q3 2021 | $573,000 | -63.2% | 58,501 | -74.7% | 0.02% | -37.0% |
Q2 2021 | $1,555,000 | -29.5% | 231,073 | -5.3% | 0.03% | -28.9% |
Q1 2021 | $2,206,000 | -4.5% | 244,068 | -29.4% | 0.04% | -9.5% |
Q4 2020 | $2,310,000 | +188.0% | 345,767 | +117.2% | 0.04% | +133.3% |
Q3 2020 | $802,000 | -37.6% | 159,200 | 0.0% | 0.02% | -35.7% |
Q2 2020 | $1,286,000 | -42.2% | 159,200 | -43.2% | 0.03% | -49.1% |
Q1 2020 | $2,224,000 | -5.1% | 280,200 | -9.7% | 0.06% | +44.7% |
Q4 2019 | $2,344,000 | – | 310,469 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 4,133,464 | $45,592,000 | 5.54% |
Stonepine Capital Management, LLC | 747,863 | $8,249,000 | 4.45% |
JW Asset Management, LLC | 444,439 | $4,902,000 | 3.12% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,655,494 | $40,320,000 | 2.15% |
ARMISTICE CAPITAL, LLC | 1,150,000 | $12,685,000 | 1.62% |
FALCON POINT CAPITAL, LLC | 855,101 | $9,432,000 | 1.27% |
Perceptive Advisors | 1,429,114 | $15,763,000 | 0.79% |
KNOTT DAVID M | 126,463 | $1,395,000 | 0.58% |
HEARTLAND ADVISORS INC | 700,000 | $7,721,000 | 0.50% |
Sio Capital Management, LLC | 91,413 | $1,008,000 | 0.48% |